HIGHFIVE SUB-CLONES ON THE MARKET
and the latest optimized virus-free subclones
yield and scalability for recombinant protein production.
BTI is the sole proprietor of HighFive™ cells
and related sub-clones.
Sf9 for malaria vaccine candidate production.
Quality of antigen produced in HighFive
is as good as if produced in human cells.
The HighFive cell line (sometimes referred to as High-Five or Hi5) is a well-established and popular tool for protein production. With the recent development of optimized virus-free sub-clones, it remains the safest and most effective platform for the Baculovirus Expression Vector System (BEVS).
BTI has partnered with researchers and companies to continue to improve the technology and make it accessible to all. The sole proprietor of the technology, BTI offers affordable licensing with complete peace of mind.
WHY HIGH FIVE
Find out why HighFive cell lines are a popular tool for protein production.
AVAILABLE CELL LINES
Use the original HighFive cell line or virus-free sub-clones.
PUBLICATIONS
Read some of the most relevant articles.
Our History: BTI – Home of the HighFive Cell Lines
Dr. Robert Granados was looking for ways to defend crops from the Cabbage Looper. During his research he made an unexpected discovery. The HighFive cell line and newer sub-clones free of nodavirus are a popular tool for recombinant protein production. Read more.
BTI is the exclusive owner of the proprietary HighFive cell line and related sub-clones. Contact us to inquire about cell lines available for testing and request commercial-use licenses.
Our Team
For licensing inquires contact licensing@btiscience.org
Connect with BTI’s Translational Program and Licensing on LinkedIn!
Subscribe to BTI's LabNotes Newsletter!
Contact:
Boyce Thompson Institute
533 Tower Rd.
Ithaca, NY 14853
607.254.1234
contact@btiscience.org
Copyright © 2023 | Boyce Thompson Institute | All rights reserved | Privacy Policy | Cookie Policy